Unit
Medizinische Onkologie und Hämatologie
ONKO · Dept. I
Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG)
Bernhard J, Senn H, Goldhirsch A, Forbes J, Thürlimann B, Marini G, Galligioni E, Gelber R, Castiglione-Gertsch M, Peterson H, Coates A, Hürny C, Rudenstam C. Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG). British journal of cancer 1998; 78:686-93.
Sep 1, 1998Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG)
Sep 1, 1998British journal of cancer 1998; 78:686-93
Bernhard J, Senn H J, Goldhirsch A, Forbes J F, Thürlimann Beat, Marini G, Galligioni E, Gelber R D, Castiglione-Gertsch M, Peterson H F, Coates A S, Hürny C, Rudenstam C M
Symmetrical infarction of the cervical spinal cord due to spontaneous bilateral vertebral artery dissection
Hundsberger T, Thömke F, Hopf H, Fitzek C. Symmetrical infarction of the cervical spinal cord due to spontaneous bilateral vertebral artery dissection. Stroke; a journal of cerebral circulation 1998; 29:1742.
Aug 1, 1998Symmetrical infarction of the cervical spinal cord due to spontaneous bilateral vertebral artery dissection
Aug 1, 1998Stroke; a journal of cerebral circulation 1998; 29:1742
Hundsberger Thomas, Thömke F, Hopf H C, Fitzek C
Use of second-line biochemical and susceptibility tests for the differential identification of coryneform bacteria
Früh M. Use of second-line biochemical and susceptibility tests for the differential identification of coryneform bacteria. Clinical Microbiology and Infection 1998; Vol. 4 June 1998
Jun 4, 1998Use of second-line biochemical and susceptibility tests for the differential identification of coryneform bacteria
Jun 4, 1998Clinical Microbiology and Infection 1998; Vol. 4 June 1998
Früh Martin
Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI
Pagani O, Price K, Fey M, Simoncini E, Thürlimann B, Cavalli F, Coates A, Crivellari D, Collins J, Lindtner J, Rudenstam C, Goldhirsch A, Gelber R, Castiglione M, O'Neill A, Senn H. Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI. European journal of cancer (Oxford, England : 1990) 1998; 34:632-40.
Apr 1, 1998Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI
Apr 1, 1998European journal of cancer (Oxford, England : 1990) 1998; 34:632-40
Pagani O, Price K, Fey M, Simoncini E, Thürlimann Beat, Cavalli F, Coates A, Crivellari D, Collins J, Lindtner J, Rudenstam C M, Goldhirsch A, Gelber R D, Castiglione M, O'Neill A, Senn H J
Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer
Lehnert M, Mross K, Schueller J, Thürlimann B, Kroeger N, Kupper H. Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer. British journal of cancer 1998; 77:1155-63.
Apr 1, 1998Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer
Apr 1, 1998British journal of cancer 1998; 77:1155-63
Lehnert M, Mross K, Schueller J, Thürlimann Beat, Kroeger N, Kupper H
Efficacy and toxicity of sequential high-dose therapy with peripheral blood stem cell support in patients with high-risk breast cancer
Hohaus S, Wallwiener D, Martin S, Voso M, Huober J, Fersis N, Bastert G, Haas R. Efficacy and toxicity of sequential high-dose therapy with peripheral blood stem cell support in patients with high-risk breast cancer. Seminars in oncology 1998; 25:7-11; discussion 45-8.
Apr 1, 1998Efficacy and toxicity of sequential high-dose therapy with peripheral blood stem cell support in patients with high-risk breast cancer
Apr 1, 1998Seminars in oncology 1998; 25:7-11; discussion 45-8
Hohaus S, Wallwiener D, Martin S, Voso M T, Huober Jens, Fersis N, Bastert G, Haas R
Analysis of the multiple interactions between IL-12 and the high affinity IL-12 receptor complex
Presky D, Minetti L, Gillessen Sommer S, Wilkinson V, Wu C, Gubler U, Chizzonite R, Gately M. Analysis of the multiple interactions between IL-12 and the high affinity IL-12 receptor complex. Journal of immunology (Baltimore, Md. : 1950) 1998; 160:2174-9.
Mar 1, 1998Analysis of the multiple interactions between IL-12 and the high affinity IL-12 receptor complex
Mar 1, 1998Journal of immunology (Baltimore, Md. : 1950) 1998; 160:2174-9
Presky D H, Minetti L J, Gillessen Sommer Silke, Wilkinson V L, Wu C Y, Gubler U, Chizzonite R, Gately M K
Subjective health estimations (SHE) in patients with advanced breast cancer: an adapted utility concept for clinical trials
Hürny C, Van Wegberg B, Bacchi M, Bernhard J, Thürlimann B, Real O, Perey L, Bonnefoi H, Coates A. Subjective health estimations (SHE) in patients with advanced breast cancer: an adapted utility concept for clinical trials. British journal of cancer 1998; 77:985-91.
Mar 1, 1998Subjective health estimations (SHE) in patients with advanced breast cancer: an adapted utility concept for clinical trials
Mar 1, 1998British journal of cancer 1998; 77:985-91
Hürny C, Van Wegberg B, Bacchi M, Bernhard J, Thürlimann Beat, Real O, Perey L, Bonnefoi H, Coates A
Regulation of the p85/p110 phosphatidylinositol 3'-kinase: stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit.
Yu J, Zhang Y, McIlroy J, Rordorf T, Orr G, Backer J. Regulation of the p85/p110 phosphatidylinositol 3'-kinase: stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit. Mol Cell Biol 1998; 18:1379-87.
Mar 1, 1998Regulation of the p85/p110 phosphatidylinositol 3'-kinase: stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit.
Mar 1, 1998Mol Cell Biol 1998; 18:1379-87
Yu J, Zhang Yan, McIlroy J, Rordorf Tamara, Orr G A, Backer J M
Spiritualität und Sinnfindung
Renz M. Spiritualität und Sinnfindung. INFO Kara 1998; 3:8-13.
Jan 1, 1998Spiritualität und Sinnfindung
Jan 1, 1998INFO Kara 1998; 3:8-13
Renz Monika
Tandem and triple high-dose chemotherapy with autologous stem cell rescue in metastatic breast cancer
Huober J, Haas R, Bastert G, Goldschmidt H, Martin S, Meyer A, Wittmann G, Hohaus S, Schneeweiss A, Wallwiener D. Tandem and triple high-dose chemotherapy with autologous stem cell rescue in metastatic breast cancer. Journal of cancer research and clinical oncology 1998; 124:690-4.
Jan 1, 1998Tandem and triple high-dose chemotherapy with autologous stem cell rescue in metastatic breast cancer
Jan 1, 1998Journal of cancer research and clinical oncology 1998; 124:690-4
Huober Jens, Haas R, Bastert G, Goldschmidt H, Martin S, Meyer A, Wittmann G, Hohaus S, Schneeweiss A, Wallwiener D
Therapy of Primary Breast Cancer in the 21st Century: A Prediction
Senn, Lampert, Thürlimann B. Therapy of Primary Breast Cancer in the 21st Century: A Prediction. Breast cancer (Tokyo, Japan) 1997; 4:213-220.
Dec 25, 1997Therapy of Primary Breast Cancer in the 21st Century: A Prediction
Dec 25, 1997Breast cancer (Tokyo, Japan) 1997; 4:213-220
Senn, Lampert, Thürlimann Beat
Autologous peripheral blood stem cell transplantation in a patient with chronic autoimmune thrombocytopenia
Skoda R, Tichelli A, Tyndall A, Hoffmann T, Gillessen Sommer S, Gratwohl A. Autologous peripheral blood stem cell transplantation in a patient with chronic autoimmune thrombocytopenia. British journal of haematology 1997; 99:56-7.
Oct 1, 1997Autologous peripheral blood stem cell transplantation in a patient with chronic autoimmune thrombocytopenia
Oct 1, 1997British journal of haematology 1997; 99:56-7
Skoda R C, Tichelli A, Tyndall A, Hoffmann T, Gillessen Sommer Silke, Gratwohl A
Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase II multicentre multinational study. Exemestane Study Group
Thürlimann B, Zurlo M, Lanzalone S, di Salle E, Murray R, Roché H, Bonneterre J, Serin D, Paridaens R, Piscitelli G. Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase II multicentre multinational study. Exemestane Study Group. European journal of cancer (Oxford, England : 1990) 1997; 33:1767-73.
Oct 1, 1997Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase II multicentre multinational study. Exemestane Study Group
Oct 1, 1997European journal of cancer (Oxford, England : 1990) 1997; 33:1767-73
Thürlimann Beat, Zurlo M G, Lanzalone S, di Salle E, Murray R, Roché H, Bonneterre J, Serin D, Paridaens R, Piscitelli G
Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International Breast Cancer Study Group (IBCSG) Trial VI
Goldhirsch A, Price K, Pagani O, Fey M, Simoncini E, Cavalli F, Coates A, Crivellari D, Forbes J, Collins J, Lindtner J, Rudenstam C, Thürlimann B, O'Neill A, Castiglione M, Gelber R, Senn H. Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International Breast Cancer Study Group (IBCSG) Trial VI. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997; 8:751-6.
Aug 1, 1997Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International Breast Cancer Study Group (IBCSG) Trial VI
Aug 1, 1997Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997; 8:751-6
Goldhirsch A, Price K, Pagani O, Fey M F, Simoncini E, Cavalli F, Coates A, Crivellari D, Forbes J, Collins J, Lindtner J, Rudenstam C M, Thürlimann Beat, O'Neill A, Castiglione M, Gelber R D, Senn H J
Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancer
Nabholtz J, Murawsky M, Alaki M, Aapro M, Drbal J, Trillet-Lenoir V, Rosso R, Rapoport B, Vandenberg T, Douma J, Deschênes L, Melnychuk D, Bezwoda W, Thürlimann B, Riva A. Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancer. Oncology (Williston Park, N.Y.) 1997; 11:25-30.
Aug 1, 1997Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancer
Aug 1, 1997Oncology (Williston Park, N.Y.) 1997; 11:25-30
Nabholtz J M, Murawsky M, Alaki M, Aapro M S, Drbal J, Trillet-Lenoir V, Rosso R, Rapoport B, Vandenberg T A, Douma J, Deschênes L, Melnychuk D, Bezwoda W R, Thürlimann Beat, Riva A
Metabolic evaluation of patients with recurrent idiopathic calcium nephrolithiasis
Hess B, Hasler-Strub U, Ackermann D, Jaeger P. Metabolic evaluation of patients with recurrent idiopathic calcium nephrolithiasis. Nephrol Dial Transplant 1997; 12:1362-8.
Jul 1, 1997Metabolic evaluation of patients with recurrent idiopathic calcium nephrolithiasis
Jul 1, 1997Nephrol Dial Transplant 1997; 12:1362-8
Hess B, Hasler-Strub Ursula, Ackermann D, Jaeger P
Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90). Swiss Group for Clinical Cancer Research (SAKK)
Thürlimann B, Castiglione M, Hsu-Schmitz S, Cavalli F, Bonnefoi H, Fey M, Morant R, Löhnert T, Goldhirsch A. Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90). Swiss Group for Clinical Cancer Research (SAKK). European journal of cancer (Oxford, England : 1990) 1997; 33:1017-24.
Jun 1, 1997Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90). Swiss Group for Clinical Cancer Research (SAKK)
Jun 1, 1997European journal of cancer (Oxford, England : 1990) 1997; 33:1017-24
Thürlimann Beat, Castiglione M, Hsu-Schmitz S F, Cavalli F, Bonnefoi H, Fey M F, Morant R, Löhnert T, Goldhirsch A
[Carcinoma-associated retinopathy in breast carcinoma and carcinoid tumor]
Holz F, Bellmann C, Steffen H, Nölle B, Huober J, Krastel H, Alexandridis E. [Carcinoma-associated retinopathy in breast carcinoma and carcinoid tumor]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 1997; 94:337-42.
May 1, 1997[Carcinoma-associated retinopathy in breast carcinoma and carcinoid tumor]
May 1, 1997Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 1997; 94:337-42
Holz F G, Bellmann C, Steffen H, Nölle B, Huober Jens, Krastel H, Alexandridis E
Exemestane experience in breast cancer treatment
Lønning P, Paridaens R, Thürlimann B, Piscitelli G, di Salle E. Exemestane experience in breast cancer treatment. The Journal of steroid biochemistry and molecular biology 1997; 61:151-5.
Apr 1, 1997Exemestane experience in breast cancer treatment
Apr 1, 1997The Journal of steroid biochemistry and molecular biology 1997; 61:151-5
Lønning P E, Paridaens R, Thürlimann Beat, Piscitelli G, di Salle E